RE/MAX (RMAX) Stephens 26th Annual Investment Conference | NASH2024 summary
Event summary combining transcript, slides, and related documents.
Stephens 26th Annual Investment Conference | NASH2024 summary
13 Jan, 2026Macroeconomic and industry outlook
Expectation for U.S. housing market to be modestly up next year, with home prices flattish to slightly up.
30-year mortgage rates and supply remain key factors influencing housing activity.
Political impacts on housing seen as neutral, with agent commissions expected to remain largely unchanged in the near term.
Normalized U.S. existing home sales projected around 5.5 million, but reaching that level may take several years.
Generational wealth transfer and pent-up demand from Millennials and Gen Z are driving continued housing demand.
Industry changes and adaptation
Major NAR practice changes: commissions no longer posted in MLS and mandatory buyer agreements before showings.
Organization responded with hybrid training and local mentorship to help agents adapt to new rules.
High agent productivity and professionalism cited as advantages in managing industry transitions.
Industry fragmentation and uncertainty are creating opportunities to recruit independent agents seeking stability.
Changes may help cleanse lower performers and part-timers from the industry, benefiting full-time professionals.
Business model, growth, and financials
Franchise model generates strong cash flow, with 65% of revenue tied to agent count and 20-25% variable with transaction volume.
U.S. agent count has declined 5-6% in recent years; focus is on acquisition and value proposition to stabilize and grow.
Revenue per agent is highest in the U.S., with international agents contributing about a tenth as much.
Franchise sales and independent broker conversions are key to boosting agent count and market share.
Diversification efforts include expanding into mortgage services and digital channels to enhance revenue streams.
Latest events from RE/MAX
- Q4 revenue and EBITDA declined, but global agent count hit a record and 2026 outlook is positive.RMAX
Q4 202520 Feb 2026 - Adjusted EBITDA rose 5.4% to $28.1M despite a 4.8% revenue decline in Q2 2024.RMAX
Q2 20241 Feb 2026 - Adjusted EBITDA rose 2% to $27.3M as cost controls and global agent growth offset U.S. declines.RMAX
Q3 202417 Jan 2026 - Adjusted EBITDA rose despite revenue decline, with international agent growth offsetting U.S. losses.RMAX
Q4 202424 Dec 2025 - Annual meeting to vote on directors, pay, equity plan, and auditor, with all proposals endorsed.RMAX
Proxy Filing1 Dec 2025 - Virtual annual meeting to vote on directors, pay, incentive plan, and auditor ratification.RMAX
Proxy Filing1 Dec 2025 - Revenue fell but margins improved as global agent growth offset North America decline.RMAX
Q1 202523 Nov 2025 - Record agent count offset U.S. declines as revenue and EBITDA fell but margin improved.RMAX
Q2 202516 Nov 2025 - Q3 2025: Revenue down, margins up, record agent count, and innovation drive resilience.RMAX
Q3 20253 Nov 2025